636 related articles for article (PubMed ID: 22592700)
1. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Longas-Tejero MA; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2012 May; (5):CD005049. PubMed ID: 22592700
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Mouly S; Longas-Tejero MA; Bergmann JF
Cochrane Database Syst Rev; 2007 Oct; (4):CD005049. PubMed ID: 17943835
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
Lafuente-Lafuente C; Mouly S; Longás-Tejero MA; Mahé I; Bergmann JF
Arch Intern Med; 2006 Apr; 166(7):719-28. PubMed ID: 16606807
[TBL] [Abstract][Full Text] [Related]
6. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
7. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
9. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
[TBL] [Abstract][Full Text] [Related]
10. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
12. Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM
Card Electrophysiol Rev; 2003 Sep; 7(3):201-7. PubMed ID: 14739713
[TBL] [Abstract][Full Text] [Related]
13. [Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Koenig A; Theolade R; Chauvin M; Brechenmacher C
Presse Med; 1993 Nov; 22(36):1827-32. PubMed ID: 8309912
[TBL] [Abstract][Full Text] [Related]
14. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
Singh BN; Mody FV; Lopez B; Sarma JS
Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Wijffels MC; Dorland R; Allessie MA
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.
Miller MR; McNamara RL; Segal JB; Kim N; Robinson KA; Goodman SN; Powe NR; Bass EB
J Fam Pract; 2000 Nov; 49(11):1033-46. PubMed ID: 11093570
[TBL] [Abstract][Full Text] [Related]
19. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
Kosior D; Opolski G; Torbicki A
Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
